Pharmacists can help with DM management via telemedicine

Pharmacists can help with DM management via telemedicine
(HealthDay)—Pharmacist use of telemedicine is a promising vehicle for improving patient management of diabetes, according to an article published in Drug Topics.

Noting that 50 percent of all drug errors involve insulin and that 97 percent of insulin overdoses occur at home, the article discussed issues relating to diabetes management and the potential for telemedicine in .

Pharmacists and pharmacy benefit managers (PBMs) are challenged in their roles to have a positive impact on insulin management. Pharmacists do not have enough information to help patients avoid , while PBMs cannot ensure proper day-to-day dosing. Telemedicine could improve the situation by providing a real-time feedback loop, allowing to track data in real time, helping patients to self-manage their condition and promote patient engagement, and allowing clinical pharmacists to intervene with their patients when necessary. Patients can enter their blood sugar reading and a telemedicine app will tell them how much insulin they need; providing real-time feedback would allow patients to follow the treatment plan and improve ' confidence, thereby improving adherence. Furthermore, having the app and its data available would improve coordination of care and tracking of medications.

"Telemedicine tools can provide a vital resource that enables PBMs and pharmacists to meaningfully impact patient outcomes and costs," according to the article. "These tools provide a mechanism for improving adherence, reducing adverse events, and compiling an accurate and up-to-date medication list."


Explore further

Pharmacists play key roles in cardiac disease management

More information: Abstract/Full Text

Copyright © 2018 HealthDay. All rights reserved.

Citation: Pharmacists can help with DM management via telemedicine (2018, April 13) retrieved 25 June 2019 from https://medicalxpress.com/news/2018-04-pharmacists-dm-telemedicine.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
10 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more